Kevin Royalty
Papers
1
Total Citations
12
H-Index
1
About
Dr. Kevin Royalty is a leading researcher in interventional pulmonology and thoracic oncology, with a focused expertise in minimally invasive, image-guided therapies for lung cancer. His key research areas encompass bronchoscopic ablation technologies, robotic-assisted bronchoscopy, and the safety evaluation of novel thermal ablation systems for peripheral lung tumors. Dr. Royalty’s major contributions include pioneering the preclinical safety assessment of microwave ablation (MWA) combined with robotic-assisted bronchoscopy, as demonstrated in his highly cited 2023 study on normal swine peripheral lung. This work, which has garnered 12 citations, provided critical foundational evidence that bronchoscopic MWA using the NEUWAVE™ FLEX system and MONARCH™ Platform is a safe and feasible approach for treating lung parenchyma, paving the way for clinical translation. By systematically evaluating device safety in a large animal model, Dr. Royalty has directly addressed a key barrier to adopting bronchoscopic ablation for early-stage lung cancer patients who are not surgical candidates. His research is instrumental in advancing the field toward more precise, less invasive treatments that reduce patient morbidity. Dr. Royalty’s work is widely recognized for its rigorous methodology and its direct impact on shaping clinical protocols and device development in interventional oncology.
Research Focus
Key Achievements
Top Papers
- 1